{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:54:01Z","timestamp":1791258841066,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,6]],"date-time":"2027-10-06T00:00:00Z","timestamp":1822780800000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R03HD105507"],"award-info":[{"award-number":["R03HD105507"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"US Food and Drug Administration","doi-asserted-by":"publisher","award":["R01 FD006003"],"award-info":[{"award-number":["R01 FD006003"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009726","name":"Foundation for Angelman Syndrome Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001951","name":"Angelman Syndrome Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001951","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jval.2025.11.021","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T16:49:53Z","timestamp":1767631793000},"page":"1781-1790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Developing Meaningful Score Differences for the Bayley-4 and Vineland-3 in Angelman Syndrome Using a Delphi Panel"],"prefix":"10.1016","volume":"29","author":[{"given":"Sonya","family":"Powers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine N.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hann","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Tillmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Thurm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristan","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Clinch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne C.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Sadhwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Gwaltney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Nelson","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Squassante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorrit","family":"Tjeertes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Vincenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Buzasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.jval.2025.11.021_bib1","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/ajmg.a.31423","article-title":"Prevalence of Angelman syndrome and Prader-Willi syndrome in Estonian children: sister syndromes not equally represented","volume":"140","author":"Oiglane-Shlik","year":"2006","journal-title":"Am J Med Genet A"},{"issue":"9","key":"10.1016\/j.jval.2025.11.021_bib2","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/ajmg.a.36058","article-title":"Angelman syndrome in Denmark. birth incidence, genetic findings, and age at diagnosis","volume":"161A","author":"Mertz","year":"2013","journal-title":"Am J Med Genet A"},{"issue":"6-7","key":"10.1016\/j.jval.2025.11.021_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejmg.2016.05.003","article-title":"Angelman syndrome in Hong Kong Chinese: a 20 years\u2019 experience","volume":"59","author":"Luk","year":"2016","journal-title":"Eur J Med Genet"},{"issue":"3-5","key":"10.1016\/j.jval.2025.11.021_bib4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000328837","article-title":"Molecular and clinical aspects of Angelman syndrome","volume":"2","author":"Dagli","year":"2012","journal-title":"Mol Syndromol"},{"key":"10.1016\/j.jval.2025.11.021_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/TACG.S57386","article-title":"Angelman syndrome: review of clinical and molecular aspects","volume":"7","author":"Bird","year":"2014","journal-title":"Appl Clin Genet"},{"issue":"8","key":"10.1016\/j.jval.2025.11.021_bib6","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/hmg\/ddg106","article-title":"Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a","volume":"12","author":"Yamasaki","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.jval.2025.11.021_bib7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.nbd.2010.04.012","article-title":"Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome","volume":"39","author":"Gustin","year":"2010","journal-title":"Neurobiol Dis"},{"issue":"4","key":"10.1016\/j.jval.2025.11.021_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124649","article-title":"Toward a broader view of Ube3a in a mouse model of Angelman syndrome: expression in brain, spinal cord, sciatic nerve and glial cells","volume":"10","author":"Grier","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jval.2025.11.021_bib9","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/DBP.0b013e3181ee408e","article-title":"A neurodevelopmental survey of Angelman syndrome with genotype-phenotype correlations","volume":"31","author":"Gentile","year":"2010","journal-title":"J Dev Behav Pediatr"},{"issue":"1","key":"10.1016\/j.jval.2025.11.021_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ajmg.a.61382","article-title":"An overview of health issues and development in a large clinical cohort of children with Angelman syndrome","volume":"182","author":"Bindels-de Heus","year":"2020","journal-title":"Am J Med Genet A"},{"issue":"10","key":"10.1016\/j.jval.2025.11.021_bib11","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1007\/s10803-023-06090-8","article-title":"Adaptive skills of individuals with Angelman syndrome assessed using the Vineland Adaptive Behavior Scales","volume":"54","author":"Gwaltney","year":"2024","journal-title":"J Autism Dev Disord"},{"issue":"2","key":"10.1016\/j.jval.2025.11.021_bib12","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s10803-020-04861-1","article-title":"Developmental skills of individuals with Angelman syndrome assessed using the Bayley-III","volume":"53","author":"Sadhwani","year":"2023","journal-title":"J Autism Dev Disord"},{"issue":"4","key":"10.1016\/j.jval.2025.11.021_bib13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ajmg.c.31536","article-title":"Angelman syndrome: current and emerging therapies in 2016","volume":"172","author":"Tan","year":"2016","journal-title":"Am J Med Genet C"},{"issue":"9-10","key":"10.1016\/j.jval.2025.11.021_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10354-015-0408-z","article-title":"Pharmacological therapies for Angelman syndrome","volume":"167","author":"Tan","year":"2017","journal-title":"Wien Med Wochenschr"},{"issue":"9","key":"10.1016\/j.jval.2025.11.021_bib19","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1038\/s41591-025-03784-7","article-title":"all TANGELO investigators. The UBE3A-ATS antisense oligonucleotide rugonersen in children with Angelman syndrome: a phase 1 trial","volume":"31","author":"Hipp","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.jval.2025.11.021_bib20","series-title":"Bayley Scales of Infant and Toddler Development Fourth Edition (Bayley-4)","author":"Bayley","year":"2019"},{"key":"10.1016\/j.jval.2025.11.021_bib21","series-title":"Vineland Adaptive Behavior Scales. 3rd ed.","author":"Sparrow","year":"2016"},{"key":"10.1016\/j.jval.2025.11.021_bib22","article-title":"Patient-Focused Drug Development: Incorporating Clinical Outcome Assessments Into Endpoints for Regulatory Decision-Making","year":"2023","journal-title":"Food and Drug Administration"},{"key":"10.1016\/j.jval.2025.11.021_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2147\/PROM.S385542","article-title":"Quantitative and qualitative exploration of meaningful change on the Vineland Adaptive Behavior Scales (Vineland\u2122-II) in children and adolescents with autism without intellectual disability following participation in a clinical trial","volume":"14","author":"Clinch","year":"2023","journal-title":"Patient Relat Outcome Meas"},{"key":"10.1016\/j.jval.2025.11.021_bib24","article-title":"A patient-centered evaluation of meaningful change on the 32-item motor function measure in spinal muscular atrophy using qualitative and quantitative data","volume":"12","author":"Duong","year":"2021","journal-title":"Front Neurol"},{"issue":"5","key":"10.1016\/j.jval.2025.11.021_bib25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/08830738231172066","article-title":"Meaningful improvements in Rett syndrome: a qualitative study of caregivers","volume":"38","author":"McGraw","year":"2023","journal-title":"J Child Neurol"},{"issue":"2","key":"10.1016\/j.jval.2025.11.021_bib26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11136-023-03543-6","article-title":"What does better look like in individuals with severe neurodevelopmental impairments? A qualitative descriptive study on SCN2A-related developmental and epileptic encephalopathy","volume":"33","author":"Downs","year":"2024","journal-title":"Qual Life Res"},{"issue":"2","key":"10.1016\/j.jval.2025.11.021_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/aur.1874","article-title":"Adaptive behavior in autism: minimal clinically important differences on the Vineland-II","volume":"11","author":"Chatham","year":"2018","journal-title":"Autism Res"},{"key":"10.1016\/j.jval.2025.11.021_bib28","first-page":"1","article-title":"Psychometric perspectives on developmental outcome and endpoint selection in treatment trials for genetic conditions associated with neurodevelopmental disorder","volume":"62","author":"Farmer","year":"2022","journal-title":"Int Rev Res Dev Disabil"},{"key":"10.1016\/j.jval.2025.11.021_bib30","series-title":"Probabilistic Models for Some Intelligence and Attainment Tests","author":"Rasch","year":"1960"},{"issue":"1","key":"10.1016\/j.jval.2025.11.021_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s11689-023-09494-w","article-title":"Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)","volume":"15","author":"Tjeertes","year":"2023","journal-title":"J Neurodev Disord"},{"key":"10.1016\/j.jval.2025.11.021_bib33","series-title":"Corporation. Trans","article-title":"Delphi Process: a methodology used for the elicitation of opinions of experts","author":"Brown","year":"1968"},{"issue":"4","key":"10.1016\/j.jval.2025.11.021_bib34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/0194599819852604","article-title":"Understanding the minimal clinically important difference (MCID) of patient-reported outcome measures","volume":"61","author":"Sedaghat","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"5","key":"10.1016\/j.jval.2025.11.021_bib35","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jclinepi.2014.07.008","article-title":"Minimally important change values of a measurement instrument depend more on baseline values than on the type of intervention","volume":"68","author":"de Vet","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jval.2025.11.021_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2025.110381","article-title":"Qualitative evaluation of meaningful change in Dravet syndrome as measured by the Vineland-3: caregiver and clinician perspectives","volume":"167","author":"Condon","year":"2025","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.jval.2025.11.021_bib37","article-title":"Parent-reported outcome measures for individuals with fragile X syndrome: clinically meaningful change thresholds","author":"Nelson","year":"2024","journal-title":"J Autism Dev Disord"},{"issue":"4","key":"10.1016\/j.jval.2025.11.021_bib38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5662\/wjm.v11.i4.116","article-title":"Delphi methodology in healthcare research: how to decide its appropriateness","volume":"11","author":"Nasa","year":"2021","journal-title":"World J Methodol"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525062102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525062102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:44:44Z","timestamp":1791258284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301525062102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1098301525062102"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2025.11.021","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing Meaningful Score Differences for the Bayley-4 and Vineland-3 in Angelman Syndrome Using a Delphi Panel","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2025.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}